Literature DB >> 4010522

Metabolic utilization and renal handling of D-lactate in men.

M S Oh, J Uribarri, D Alveranga, I Lazar, N Bazilinski, H J Carroll.   

Abstract

This study was carried out to investigate the renal handling of d- and l-lactate and the extent of their metabolism in men. Ten healthy male subjects were given an intravenous (IV) infusion of a racemic mixture of d- and l-lactate. At an infusion rate of 1.0 to 1.3 meq/kg body weight of each isomer, d-lactate achieved a concentration in plasma of 1.7 to 3.0 meq/L, and l-lactate 2.8 to 4.2 meq/L. At these levels, fractional excretion of d-lactate ranged from 40% to 65%, while fractional excretion of l-lactate was always less than 5%. At a higher infusion rate, 1.8 to 2.0 meq/kg/h, plasma concentrations of d- and l-lactate reached 4.5 to 6.0 meq/L, and 4.0 to 6.7 meq/L, respectively. Fractional excretion of d-lactate then ranged from 61% to 100%, while that of l-lactate ranged from 9% to 30%. At plasma concentrations of d-lactate less than 3.0 meq/L, reabsorption of l-lactate was nearly complete, but when plasma d-lactate exceeded 3.0 meq/L, reabsorption of l-lactate was considerably impaired. Similarly, for a given concentration of plasma d-lactate, its reabsorption was more efficient when the plasma l-lactate concentration and fractional excretion of l-lactate were low than when they were high. At an infusion rate of d-lactate of 1.0 to 1.3 meq/L, about 90% of the infused lactate was metabolized, and at a higher infusion rate, still more than 75% of the infused lactate was metabolized.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4010522     DOI: 10.1016/0026-0495(85)90088-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  18 in total

1.  Controversies about the use of serological markers in diagnosis of inflammatory bowel disease.

Authors:  Qin Xie; Hua-Tian Gan
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

2.  D-lactic acidosis and ataxia in a man with Crohn disease.

Authors:  Paul D James; David Black; Ayelet Kuper; Fred Saibil
Journal:  CMAJ       Date:  2010-01-18       Impact factor: 8.262

3.  Hyperuricemia and gout caused by missense mutation in d-lactate dehydrogenase.

Authors:  Max Drabkin; Yuval Yogev; Lior Zeller; Raz Zarivach; Ran Zalk; Daniel Halperin; Ohad Wormser; Evgenia Gurevich; Daniel Landau; Rotem Kadir; Yonatan Perez; Ohad S Birk
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

Review 4.  Short bowel syndrome.

Authors:  M D Stringer; J W Puntis
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

5.  Severe lactic acidosis in patient receiving continuous ambulatory peritoneal dialysis.

Authors:  I H Khan; G R Catto; A M MacLeod
Journal:  BMJ       Date:  1993-10-23

6.  Colonic lactate metabolism and D-lactic acidosis.

Authors:  H Hove; P B Mortensen
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

7.  Fecal lactate and short bowel syndrome.

Authors:  D Bustos; S Pons; J C Pernas; H Gonzalez; M I Caldarini; K Ogawa; J A De Paula
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199

8.  D-Lactate altered mitochondrial energy production in rat brain and heart but not liver.

Authors:  Binbing Ling; Fei Peng; Jane Alcorn; Katharina Lohmann; Brian Bandy; Gordon A Zello
Journal:  Nutr Metab (Lond)       Date:  2012-02-01       Impact factor: 4.169

Review 9.  D-lactic acidosis: an underrecognized complication of short bowel syndrome.

Authors:  N Gurukripa Kowlgi; Lovely Chhabra
Journal:  Gastroenterol Res Pract       Date:  2015-04-22       Impact factor: 2.260

Review 10.  D-lactic acidosis in humans: review of update.

Authors:  Kyung Pyo Kang; Sik Lee; Sung Kyew Kang
Journal:  Electrolyte Blood Press       Date:  2006-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.